S1PR1 and B-cell chronic lymphocytic leukemia: When CLL cells were treated with idelalisib for 16 h before the assay, they displayed marked TEM toward S1P (p = 0.043), the amount of TEM observed correlating with the level of S1PR1 expression at the end of the preincubation period.